Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T62581 | PPARγ agonist 6 | ||
PPARγ agonist 6 (Compound 12) 是一种选择性 PPARγ 的有效激动剂。PPARγ agonist 6 具有潜力进行癌症疾病的研究。 | |||
T15453 |
GW7647
2-[[4-[2-[[环己基氨基)羰基](4-环己基丁基)氨基]乙基]苯基]硫基]-2-甲基丙酸 |
PPAR | DNA Damage/DNA Repair; Metabolism |
GW7647 是一种PPARα有效激动剂,对人 PPARα、PPARγ 和 PPARδ 的EC50值分别为 6、1.1 和 6.2 μM。 | |||
T7159 |
L-165041
|
PPAR | DNA Damage/DNA Repair; Metabolism |
L-165041 是一种细胞渗透性 PPARδ激动剂,可在 NIH-PPARδ 细胞中诱导脂肪细胞分化,对 PPARδ 和 PPARγ 的 Ki 值分别为 6 nM 和 约 730 nM。 | |||
T35638 |
SR 1903
|
||
SR 1903 is a modulator of retinoic acid receptor-related orphan receptor γ (RORγ) and liver X receptor (LXR).1 It is an inverse agonist of RORγ (IC50 = ~100 nM in a cell-based reporter assay) and an agonist of LXR. It also binds to peroxisome proliferator-activated receptor γ (PPARγ; IC50 = 209 nM) but does not activate it. SR 1903 (10 μM) inhibits LPS-induced expression of triggering receptor expressed on myeloid cells 1 (TREM-1) in RAW 264.7 cells. It also inhibits LPS-induced expression of th... | |||
T35468 |
(±)19(20)-EDP Ethanolamide
|
||
(±)19(20)-EDP ethanolamide is an ω-3 endocannabinoid epoxide and cannabinoid (CB) receptor agonist (EC50s = 108 and 280 nM for CB1 and CB2, respectively). It is produced through direct epoxygenation of docosahexaenoyl ethanolamide by cytochrome P450 (CYP) epoxygenases. (±)19(20)-EDP ethanolamide (25 μM) reduces the viability of 143B metastatic osteosarcoma cells. It decreases the production of IL-6 and increases the production of IL-10 when used at concentrations ranging from 2.5 to 10 μM in BV-... |